IGES Pharma at BIO Japan 2024

BIO Japan 2024 will take place in Yokohama from October 9 to 11. This event consists of three exhibitions: “Bio Japan”, which is the oldest biotechnology exhibition in the world (since 1986), “Regenerative Medicine JAPAN”, which aims to accelerate and industrialize research and development in the field of regenerative medicine, and “health TECH JAPAN”, which offers a fusion of digital technology and life sciences. IGES Pharma is taking part in the conference with experts from the life sciences sector. The aim is to engage in dialogue with researchers, companies and associations on international market access and reimbursement strategies for medical innovations.

The ongoing harmonization of health technology assessments (HTAs) in Europe, one of the most far-reaching changes in EU pharmaceutical legislation, will be an important topic in this year's discussions. As stakeholders, IGES Group companies were involved in the public consultations on the development of guidelines and guidance documents as part of the EUnetHTA21 activities.
IGES Pharma has been active in Asia for several years, where the biotechnological research landscape is producing significant innovations. In Japan, in particular, there is a remarkable biotech start-up scene with many promising drug candidates in late-stage clinical development. In addition, there exists a broad-based pharmaceutical industry with many large and medium-sized, globally successful companies.

The IGES Group as a whole offers a broad spectrum of research and consulting services for global developers and manufacturers of pharmaceuticals, medical devices and digital health applications. The services support almost all phases of product life cycle management for new developments. They are focused on the most important European healthcare markets.